Joseph S Mc Cracken Lumos Pharma, Inc. (LUMO) insider trading activity

Joseph S Mc Cracken is Director of LUMOS PHARMA, INC.. Currently has a direct ownership of 0 shares of LUMO, which is worth approximately $0. The most recent transaction as insider was on Dec 12, 2024, when has been sold 15,721 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Joseph S McCracken Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2024	SELL Sale (or disposition) back to the issuer	-	15,721 Reduced 100.0%	0 Common Stock
Nov 16 2022	BUY Open market or private purchase	$20,120 $5.03 p/Share	4,000 Added 20.28%	15,721 Common Stock
Aug 25 2022	BUY Open market or private purchase	$27,262 $8.6 p/Share	3,170 Added 21.29%	11,721 Common Stock
Aug 11 2021	BUY Open market or private purchase	$56,436 $7.55 p/Share	7,475 Added 46.64%	8,551 Common Stock
May 20 2021	BUY Grant, award, or other acquisition	-	367 Added 25.43%	1,076 Common Stock

Also insider at

SVRA

Savara Inc Healthcare

KIN

Kindred Biosciences, Inc.

Director

JSM